Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
Whitaker H, Findlay B, Zitha J, Goudie R, Hassell K, Evans J, Kalapotharakou P, Agrawal U, Kele B, Hamilton M, Moore C, Byford R, Stowe J, Robertson C, Couzens A, Jamie G, Hoschler K, Pheasant K, Button E, Quinot C, Jones T, Anand S, Watson C, Andrews N, de Lusignan S, Zambon M, Williams C, Cottrell S, Marsh K, McMenamin J, Lopez Bernal J. Whitaker H, et al. Among authors: robertson c. Influenza Other Respir Viruses. 2024 May;18(5):e13284. doi: 10.1111/irv.13284. Influenza Other Respir Viruses. 2024. PMID: 38773753 Free PMC article.
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales.
Kerr S, Bedston S, Bradley DT, Joy M, Lowthian E, Mulholland RM, Akbari A, Hobbs FDR, Katikireddi SV, de Lusignan S, Rudan I, Torabi F, Tsang RSM, Lyons RA, Robertson C, Sheikh A. Kerr S, et al. Among authors: robertson c. Int J Epidemiol. 2023 Feb 8;52(1):22-31. doi: 10.1093/ije/dyac199. Int J Epidemiol. 2023. PMID: 36272418 Free PMC article.
A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection.
Calvert C, Carruthers J, Denny C, Donaghy J, Hopcroft LEM, Hopkins L, Goulding A, Lindsay L, McLaughlin T, Moore E, Taylor B, Loane M, Dolk H, Morris J, Auyeung B, Bhaskaran K, Gibbons CL, Katikireddi SV, O'Leary M, McAllister D, Shi T, Simpson CR, Robertson C, Sheikh A, Stock SJ, Wood R. Calvert C, et al. Among authors: robertson c. Nat Commun. 2023 Jan 6;14(1):107. doi: 10.1038/s41467-022-35771-8. Nat Commun. 2023. PMID: 36609574 Free PMC article.
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study.
Tsang RS, Joy M, Byford R, Robertson C, Anand SN, Hinton W, Mayor N, Kar D, Williams J, Victor W, Akbari A, Bradley DT, Murphy S, O'Reilly D, Owen RK, Chuter A, Beggs J, Howsam G, Sheikh A, Hobbs FR, de Lusignan S. Tsang RS, et al. Among authors: robertson c. Euro Surveill. 2023 Jan;28(3):2200195. doi: 10.2807/1560-7917.ES.2023.28.3.2200195. Euro Surveill. 2023. PMID: 36695484 Free PMC article.
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
Joy M, Agrawal U, Fan X, Robertson C, Anand SN, Ordonez-Mena J, Byford R, Goudie R, Jamie G, Kar D, Williams J, Marsden GL, Tzortziou-Brown V, Sheikh SA, Hobbs FDR, de Lusignan S. Joy M, et al. Among authors: robertson c. Lancet Reg Health Eur. 2023 Jul 18;32:100681. doi: 10.1016/j.lanepe.2023.100681. eCollection 2023 Sep. Lancet Reg Health Eur. 2023. PMID: 37671127 Free PMC article.
Developing the EAVE III platform for future health crises.
Simpson CR, Robertson C, McMenamin J, Ritchie LD, Sheikh A. Simpson CR, et al. Among authors: robertson c. Lancet Infect Dis. 2023 Nov;23(11):1223-1225. doi: 10.1016/S1473-3099(23)00626-6. Epub 2023 Oct 12. Lancet Infect Dis. 2023. PMID: 37839426 No abstract available.
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Bedston S, Almaghrabi F, Patterson L, Agrawal U, Woolford L, Anand SN, Joy M, Crawford A, Goudie R, Byford R, Abbasizanjani H, Smith D, Laidlaw L, Akbari A, Sullivan C, Bradley DT, Lyons RA, de Lusignan S, Hobbs FDR, Robertson C, Sheikh SA, Shi T. Bedston S, et al. Among authors: robertson c. Lancet Reg Health Eur. 2023 Dec 12;37:100816. doi: 10.1016/j.lanepe.2023.100816. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38162515 Free PMC article.
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
Whitaker HJ, Willam N, Cottrell S, Goudie R, Andrews N, Evans J, Moore C, Agrawal U, Hassell K, Gunson R, Zitha J, Anand S, Sebastian-Pillai P, Kalapotharakou P, Okusi C, Hoschler K, Jamie G, Kele B, Hamilton M, Couzens A, Quinot C, Pheasant K, Byford R, Marsh K, Robertson C, de Lusignan S, Williams C, Zambon M, McMenamin J, Watson CH. Whitaker HJ, et al. Among authors: robertson c. Influenza Other Respir Viruses. 2024 May;18(5):e13295. doi: 10.1111/irv.13295. Influenza Other Respir Viruses. 2024. PMID: 38744684 Free PMC article.
3,185 results